Page last updated: 2024-10-27

flufenamic acid and Autosomal Recessive Chronic Granulomatous Disease

flufenamic acid has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domínguez-Luis, M1
Herrera-García, A1
Arce-Franco, M1
Armas-González, E1
Rodríguez-Pardo, M1
Lorenzo-Díaz, F1
Feria, M1
Cadenas, S1
Sánchez-Madrid, F1
Díaz-González, F1

Other Studies

1 other study available for flufenamic acid and Autosomal Recessive Chronic Granulomatous Disease

ArticleYear
Superoxide anion mediates the L-selectin down-regulation induced by non-steroidal anti-inflammatory drugs in human neutrophils.
    Biochemical pharmacology, 2013, Jan-15, Volume: 85, Issue:2

    Topics: ADAM Proteins; ADAM17 Protein; Adolescent; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Co

2013